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A B S T R A C T

Objectives: In the United States, Black women are disproportionately afﬂicted with prenatal insomnia.
Although cognitive-behavioral therapy for insomnia (CBTI) may represent a strategy to reduce disparities in
insomnia, racial minorities attend fewer healthcare appointments and have poorer outcomes from prenatal
care and mental health treatment relative to white patients. The present study examined differences in treatment engagement and patient-reported outcomes in non-Hispanic Black and white pregnant women receiving digital CBTI.
Methods: Secondary analysis of 39 pregnant women with clinical insomnia who received digital CBTI. Treatment engagement was operationalized as the number of sessions completed (4 considered an adequate
dose). Treatment outcomes were assessed using the Insomnia Severity Index (ISI; insomnia) and Pittsburgh
Sleep Quality Index (PSQI; global sleep disturbance).
Results: Black women were 4 times more likely than white women to discontinue CBTI before receiving an
adequate dose (8.3% vs. 33.3%). Regarding treatment outcomes, white women reported a mean reduction of
5.75 points on the ISI and a reduction of 3.33 points on the PSQI (Cohen’s dz = 1.10-1.19). By comparison,
Black women reported reductions of 2.13 points on the ISI and 1.53 points on the PSQI, which were statistically non-signiﬁcant. Differences in treatment engagement did not account for the disparities in patientreported outcomes.
Conclusions: During pregnancy, Black women completed fewer CBTI sessions and experienced poorer treatment outcomes in response to digital CBTI relative to white women. Enhancements to insomnia therapy and
its digital delivery may improve adherence and outcomes in Black pregnant women.
© 2022 National Sleep Foundation. Published by Elsevier Inc. All rights reserved.

Introduction
In the United States, long-standing social and structural racism
has put Black women at much higher risk for mental illness and
adverse pregnancy outcomes—including hypertension and preterm
birth1-6—than white women. Importantly, racism is associated with
greater insomnia among Black Americans,7,8 thus, it is unsurprising
that Black women are 50% more likely than white women to endorse
clinical insomnia during pregnancy.9 As prenatal insomnia increases
risk for maternal depression,10 gestational hypertension,11 preterm
birth,12 and other adverse outcomes, interest has grown in the role of
poor sleep in perinatal complications.13,14 Given the contribution of
*Corresponding author: David A. Kalmbach, PhD, 39450 W 12 Mile Rd., Novi, MI
48377, USA.
E-mail address: dkalmba1@hfhs.org (D.A. Kalmbach).

sleep problems to racial disparities in perinatal complications, one
strategy to reduce the disproportionate burden of insomnia for Black
pregnant women is to identify insomnia treatments that are equally
effective across racial groups in pregnancy.
The recommended treatment for insomnia disorder in the general
patient population is cognitive-behavioral therapy for insomnia
(CBTI),15 Recently, data from randomized controlled trials (RCTs) support CBTI efﬁcacy in pregnant women when delivered in-person16
and digitally,17,18 but about half of pregnant CBTI recipients do not
adequately respond to therapy.16-18
A burgeoning literature highlights alarming racial disparities in
mental health treatment outcomes among minoritized people in the
United States, particularly Black Americans, who experience greater
barriers to engage in and beneﬁt from mental health treatment.19-21
Despite racial disparities in mental health treatment engagement
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and outcomes, clinical research in insomnia disorder treatment suggests CBTI may be equally effective across races.22-24 That is, race is
not a reliable predictor of CBTI response in the general insomnia
patient population. On the other hand, RCT data suggest that Black
insomnia patients endorse higher levels of insomnia after treatment
than white patients, even when race was not a signiﬁcant moderator.24 Race has not been thoroughly examined as a pretherapy factor
associated with CBTI response in the pregnant population. This is an
important gap in the literature as pregnancy is a stressful period in
life that may exacerbate social determinants of health and potentiate
racial disparities in treatment engagement and response. Given the
high prevalence of insomnia among Black pregnant women,9 available treatment options must be accessible and effective across racial
groups.
The present study was a secondary analysis of an RCT that supported the efﬁcacy of digital CBTI in pregnant women with clinically
signiﬁcant insomnia symptoms.18 We analyzed data from CBTI
patients who self-identiﬁed as non-Hispanic Black and non-Hispanic
white (the only 2 racial groups with sufﬁcient representation for
analysis) to achieve 2 primary goals. First, we sought to determine
whether treatment engagement differed by race. Consistent with the
literature on racial disparities in treatment engagement,19-21 we predicted that Black women would complete fewer sessions of digital
CBTI than white women, and thus would be less likely to receive an
adequate dose of CBTI (operationalized as  4 sessions25). Second, we
tested for racial disparities in patient-reported outcomes of insomnia
symptoms and sleep quality after CBTI. We predicted that Black
women would have poorer response (operationalized as reduction in
symptoms) to CBTI than white women. Notably, our team previously
identiﬁed refractory cognitive arousal (cognitive arousal symptoms
that do not alleviate with treatment) as a robust predictor of poor
CBTI response.26 As the present study examines racial disparities in
CBTI response, we evaluated whether race-related differences were
evident when controlling for refractory cognitive arousal.

Finally, we conducted exploratory analyses to disentangle effects
of race and treatment engagement in treatment response. We
hypothesized that race-related differences in CBTI response would be
non-signiﬁcant after accounting for differences in treatment engagement.
Methods
Study design
The trial was registered at ClinicalTrials.gov (#NCT03596879). We
invited women within our 6-hospital health system who were nearing or entering the third trimester of pregnancy (identiﬁed via ICD
codes in electronic medical records) to participate in an RCT comparing the efﬁcacy of digital CBTI vs. digital sleep education control.
Women interested in participating were screened for eligibility via
an online survey. Eligible participants were randomized to digital
CBTI or control. Full details on study methods and primary efﬁcacy
results are reported elsewhere.18 This study was approved by the
Institutional Review Board at the study site. All patients provided
written informed consent.
In this secondary analysis of racial disparities in CBTI engagement
and patient outcomes, we analyzed only data from women who selfidentiﬁed as non-Hispanic Black (n = 15) and non-Hispanic white (n =
24); the only 2 racial groups with sufﬁcient representation for comparison. See Fig. 1 for study enrollment diagram.
Study intervention
Digital CBTI. Patients randomized to CBTI completed the Sleepio
program, which is efﬁcacious in pregnancy,17,18,27 via the internet
(www.sleepio.com, Big Health Inc). Sleepio is led by a virtual therapist avatar who is depicted as a white male and involves 6 sessions
that cover behavioral sleep strategies, cognitive therapy, relaxation,

Fig. 1. Patient enrollment ﬂow diagram
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and sleep hygiene. To avoid excessive sleepiness, we modiﬁed the
program so that time in bed could not be prescribed < 6 hours in
sleep restriction.
Study variables
All study variables were assessed during pregnancy via online surveys in Qualtrics at pre-treatment assessment (1-2 weeks before
CBTI) and post-treatment assessment (1 week after completing or
discontinuing CBTI).
Sociodemographics, health information, and perinatal health. At
screening, patients provided sociodemographic and health information, including age, race, marital status, poverty (annual income
<$20,000), and parity. Patients reported whether they snore (Yes/
No). Body mass index (BMI) was derived from electronic medical
records: we analyzed BMI recorded at initial obstetrics appointment,
which is a more robust predictor of prenatal sleep problems than
BMI later in pregnancy.9
Treatment engagement was operationalized as number of sessions completed, which was derived from the Sleepio clinician portal.
As a previous study evaluating CBTI dose-response showed that
attending 4 sessions is adequate, we used this dose to deﬁne completion (referred to as “CBTI completers” below).25
Patient-reported outcomes. As we treated women in the third trimester (mean gestational age when completing CBTI was 36 weeks),
we assessed post-treatment outcomes 1 week after treatment to
minimize likelihood that patients would deliver before the posttreatment assessment. As such, post-treatment surveys were oriented to measure symptoms over the previous week.
The Insomnia Severity Index (ISI) measured insomnia symptom
severity.28,29 The original assessment window for the ISI is the prior 2
weeks. Scores range from 0 to 28, with higher scores indicating
greater severity. ISI  10 has excellent sensitivity (.842) and speciﬁcity (.812) for detecting DSM-5 insomnia disorder in pregnant
women.30 Moreover, ISI scores  7 represent remission in clinical trials29 and yield adequate sensitivity (.700) and excellent speciﬁcity
(.889) for detecting good sleep in pregnancy.30
Global sleep disturbance was measured using the Pittsburgh Sleep
Quality Index31 (PSQI), which assesses a wide range of sleep parameters over the previous month, including sleep duration, sleep latency,
sleep aid use, and sleep difﬁculties related to insomnia, breathing difﬁculties, environmental stimuli, and other factors. A global cutoff
score of PSQI > 5 differentiates poor sleepers from good sleepers,
which has been supported in pregnancy.30 In addition to measuring
global sleep disturbance, we used the PSQI to assess habitual sleep
duration (item #4a). Short sleep was operationalized as  6 hours of
nightly sleep.
Nocturnal cognitive arousal was measured using the Pre-Sleep
Arousal Scale’s Cognitive factor (PSASC),32 which has been validated
for use in pregnant women.30 PSASC scores range from 8 to 40, with
higher scores indicating greater cognitive arousal while trying to fall
asleep at night. Refractory cognitive arousal—that is, PSASC scores
that do not alleviate with treatment—is a robust predictor of poor
CBTI response.26 In the present study, DPSASC represents change in
PSASC and is operationalized as PSASCpost-treatment
PSASCpre-treatment. Thus, DPSASC scores  0 indicate refractory cognitive arousal
(ie, PSASC scores do not decrease with CBTI). PSASC is included to
rule out any potential confound between race and refractory cognitive arousal on CBTI response.

3

Results section when consistent with the overall pattern of study
ﬁndings. We analyzed data from 39 CBTI patients who self-identiﬁed
racially as non-Hispanic Black or non-Hispanic white. We report sociodemographics and pre-treatment clinical symptoms for the full
sample and separately by race.
The ﬁrst study goal was to examine whether treatment engagement differed by race; the primary endpoint was number of sessions
completed. We conducted an independent samples t-test comparing
number of sessions completed between white and Black women and
then a 2 £ 2 chi-square analysis comparing rates of CBTI completion
( 4 sessions) by race.
The second study goal was to determine whether treatment outcomes differed by race; the primary endpoints were changes in ISI
and PSQI from pre-treatment to post-treatment. Using independent
samples t-tests, we compared changes in ISI/PSQI to evaluate
whether symptom reductions differed between Black and white CBTI
patients. We then conducted post hoc paired samples t-tests separately by race to explore whether reductions in ISI/PSQI were signiﬁcant within white and Black CBTI patients and to estimate effect sizes
within each racial group. Effect sizes for paired samples t-tests
accounted for the correlated nature of the data, reported as Cohen’s
dz.33
We then conducted an exploratory analysis of interrelationships
among race, treatment engagement, and CBTI response. Using multivariate regression, we regressed post-treatment ISI onto race and sessions completed while controlling for pre-treatment ISI, refractory
cognitive arousal, marital status, poverty, BMI, short sleep duration.
The goal of this analysis was to determine whether race predicted
post-treatment ISI even after accounting for the effects of treatment
engagement. This exploratory model was then repeated for change in
PSQI as the primary endpoint.
Results
Sample characteristics
Of the 39 participants included in this secondary analysis, 24 selfidentiﬁed as non-Hispanic white, and 15 self-identiﬁed as non-Hispanic Black. The median gestational age at the start of CBTI was 29
weeks. Although pre-treatment insomnia severity did not differ
between groups, Black women were nearly twice as likely to report
short sleep duration ( 6 h/night) than white women (73.3% vs.
37.5%). See Table 1 for baseline characteristics for the full sample and
by race.
Treatment engagement
Treatment engagement was high overall, as indicated by a mean,
median, and mode of 6 sessions completed (ie, the maximum available); 32 of 39 (82.1%) received an adequate CBTI dose (4 sessions).
In support of our hypothesis regarding treatment engagement, we
observed differences in session attendance by race: Black women
completed, on average, 1.34 fewer sessions than white women (4.20
§ 2.24 vs. 5.54 § 0.93; t [37]=2.61, p = .013, Cohen’s d = .78). Consequently, Black women were 4.1 times more likely than white women
to discontinue CBTI before receiving an adequate dose (33.3% vs. 8.3%
premature discontinuation rate, p = .048; Table 1). Notably, gestational age after CBTI did not differ by race (p = .504). See Table 1 for
number of sessions completed and CBTI completion rates for the full
sample and by race.

Analysis plan
Treatment outcomes
Analyses were performed in SPSS version 26 (IBM Corp) with
alpha set at .05. Given the small sample size, we acknowledged test
results approaching statistical signiﬁcance (.05< p < .10) in the

Insomnia (ISI). An independent samples t-test showed that mean
reductions in insomnia symptoms were over twice as large for white
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Table 1
Patient characteristics and engagement metrics for digital CBTI patients

Sample size
Age in y (M § SD)
Gestational age when starting CBTI
Poverty (n;%)
Obesity (BMI  35) (n;%)
Marital status (n,%)
Multiparous (n;%)
Snore (n;%)
Gestational onset of insomnia (n;%)
ISI
PSQI
Sleep duration (h)
Short sleep (6 h; n;%)
Number of sessions completed (M § SD)
CBTI completers (4 sessions; n;%)
DPSASC (change in cognitive arousal; M § SD)

All subjects

White

Black

39
28.95 § 4.51
29.20 § 1.00
7; 17.9%
2; 7.1%
26; 66.7%
16; 41.0%
19; 48.7%
9; 23.1%
14.51 § 3.35
9.41 § 2.60
6.35 § 1.12
20; 51.3%
5.03 § 1.68
32; 82.1%
-6.33 § 8.12

24
29.46 § 4.72
29.00 § .98
4; 16.7%
2; 11.1%
21; 87.5%
11; 45.8%
12; 50.0%
4; 16.7%
14.79 § 3.34
9.38 § 2.75
6.67 § 1.08
11; 73.3%
5.54 § 0.93
22; 91.7%
-7.38 § 7.98

15
28.13 § 4.17
29.53 § .92
3; 20.0%
0; 0.0%
5; 33.3%
5; 33.3%
7; 46.7%
5; 33.3%
14.07 § 3.43
9.47 § 2.45
5.83 § 1.03
9; 37.5%
4.20 § 2.24
10; 66.7%
-4.00 § 8.36

t (37) = -0.89, p = .379
t (37) = 1.70, p = .098
x2 = 0.07, p = .792
x2 = 1.20, p = .274
x2 = 12.19, p < .001
x2 = 0.60, p = .440
x2 = 0.04, p = .839
x2 = 1.44, p = .229
t (37) = -0.65, p = .518
t (37) = 0.11, p = .916
t (37) = -2.39, p = .022
x2 = 4.74, p = .029
t (37) = -2.61, p = .013
x2 = 3.92, p = .048
t (37) = 1.26, p = .215

Note: BMI, body mass index; ISI, insomnia severity index; M, mean; n, number; PSQI, Pittsburgh Sleep Quality Index; SD, standard deviation; Sleep Duration, assessed via PSQI item 4a, reported in hours (h); Short Sleep, reported  6 hours per night on
the PSQI item 4a; %, percentage; DPSASC, post-treatment PSASC minus pre-treatment PSASC.

women relative to Black women after CBTI (-5.75 § 5.04 vs. -2.13 §
5.74; t [37] = -2.07, p = .046, Cohen’s d = .67; See Fig. 2). A paired samples t-test showed that ISI reductions in white women were very
large (t [23] = -5.59, p < .001, Cohen’s dz = 1.19), whereas ISI scores
did not signiﬁcantly change among Black women (t [15] = -1.44, p =
.172, Cohen’s dz = .42). Post hoc descriptives showed that the posttreatment ISI mean § standard deviation for white women was 9.04
§ 5.12, which is slightly below the threshold for detecting DSM-5
insomnia disorder in pregnancy. By comparison, Black women had a
post-treatment ISI mean of 11.93 § 6.61, which is above the cutoff
for DSM-5 insomnia disorder in this population. Descriptive data
showed that 41.7% of white women reported remission on the ISI (
7) after CBTI, compared with 26.7% of Black women. These rates suggest that white women may be 1.56 times more likely to remit from
insomnia after digital CBTI than Black women.
Sleep disturbance (PSQI). An independent samples t-test comparing changes in PSQI between groups revealed a statistical trend suggesting that white women may respond more favorably to CBTI than
Black women (-3.33 § 3.03 vs. -1.53 § 3.34; t [37] = 1.74, p = .091,
Cohen’s d = .56; See Fig. 3). A paired samples t-test showed that the
PSQI reduction in white women was very large (t [23] = -6.31, p <
.001, Cohen’s dz = 1.10), whereas PSQI scores do not signiﬁcantly
change in Black women (t [15] = -1.78, p = .097, Cohen’s d = .41). After
CBTI, mean PSQI scores for both white women (6.04 § 2.80) and Black
women (7.93 § 3.37) remained above the PSQI >5 cutoff indicating
poor sleep quality. Along these lines, 12/24 (50.0%) of white women

Fig. 2. Mean (and 95% CI) Insomnia Severity Index (ISI) scores at pre-treatment and
post-treatment for non-Hispanic white (n = 24) and Black (n = 15) pregnant CBTI
patients

reported good sleep after CBTI (PSQI  5), whereas only 5/15 (33.3%)
of Black women reported good sleep after CBTI.
Disentangling effects of race and treatment engagement in treatment
response
Next, we examined associations among treatment response, session attendance, and race. A comparison of CBTI completers and noncompleters suggested that completers may experience greater reductions in ISI than non-completers (-5.09 § 5.47 vs. -1.00 § 4.90; t
[37] = -1.82, p = .076, Cohen’s d = .79). As race, treatment response,
and treatment engagement were interrelated, we conducted multivariate regression analyses controlling for potential confounders
known to associate with insomnia and race.
Insomnia (ISI). A multiple regression model showed that Black
women reported ISI scores 5.52 points higher than white women
after CBTI when controlling for adequate dose, refractory cognitive
arousal, pre-treatment ISI, poverty, short sleep, marital status, and
BMI  35 (Table 2). Notably, patients with refractory cognitive
arousal reported ISI scores that were 7.82 points higher after treatment relative to patients whose cognitive arousal decreased with
CBTI (p = .001).
Insomnia Post hoc. Among patients with an adequate dose of CBTI,
a paired samples t-test showed that white women who completed 
4 sessions of CBTI had a mean ISI reduction of 6.18 § 4.90, which was

Fig. 3. Mean (and 95% CI) Pittsburgh Sleep Quality Index (PSQI) scores at pre-treatment and post-treatment for non-Hispanic white (n = 24) and Black (n = 15) pregnant
CBTI patients
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Table 2
Regressing post-treatment sleep symptoms on race, treatment engagement, and
relevant covariates

Insomnia Severity Index
Race (Black)
Completed  4 sessions
ISI, pre-treatment
Married
Poverty (< $20,000)
BMI  35
Short sleep ( 6 h/night)
DPSASC  0
Pittsburgh Sleep Quality Index
Race (Black)
Completed  4 sessions
PSQI, pre-treatment
Married
Poverty (< $20,000)
BMI  35
Short sleep ( 6 h/night)
DPSASC  0

b (SE)

b

t-statistic

p-value

5.52 (1.61)
-2.77 (1.80)
1.04 (.19)
1.29 (1.74)
-3.73 (2.10)
3.81 (2.71)
-1.39 (1.37)
7.82 (1.90)

.51
-.21
.71
.11
-.22
.19
-.13
.53

3.42
-1.54
5.45
0.74
-1.78
1.41
-1.02
4.12

.003
.141
<.001
.466
.091
.175
.321
.001

4.33 (1.07)
.46 (1.17)
.41 (.20)
3.73 (1.13)
1.14 (1.37)
-.14 (1.76)
-.06 (1.15)
4.51 (1.23)

.72
.06
.39
.56
.12
-.01
-.01
.55

4.06
0.40
2.09
3.31
0.83
-0.08
-0.05
3.67

.001
.695
.050
.004*
.415
.937
.958
.002

Note: b (SE), unstandardized beta coefﬁcient and standard error; ISI, insomnia
severity index; p-value, signiﬁcance value for each predictor; PSQI, Pittsburgh Sleep
Quality Index; Sleep Duration, assessed via PSQI item 4a, reported in hours (h);
Short Sleep, reported  6 hours per night on the PSQI item 4a; t-statistic, signiﬁcance test for each predictor; b, standardized beta coefﬁcient; DPSASC  0, refractory cognitive arousal.
* Signiﬁcant p-value interpreted as erroneous.

a very large effect (t [21] = -5.92, p < .001, Cohen’s dz = 1.32). By comparison, we observed a non-signiﬁcant change in ISI scores among
Black women who completed  4 sessions of CBTI (-2.7 § 6.15; t
[9] = -1.39, p = .198, Cohen’s dz = .49).
Sleep disturbance (PSQI). We repeated this multivariate model for
PSQI, which revealed that Black women reported higher PSQI scores
after CBTI relative to white women when controlling for session
attendance, refractory cognitive arousal, pre-treatment PSQI, poverty,
short sleep, and BMI  35 (Table 2). Once again, refractory cognitive
arousal was associated with poorer CBTI response as indicated by
PSQI outcomes (b=4.51, p = .002). Although marital status was a signiﬁcant predictor, this was interpreted as an erroneous ﬁnding based
on a null bivariate analysis examining changes in PSQI between married and unmarried women (p = .745) and its inconsistency with the
ISI model described above.
Post hoc. A paired samples t-test showed that white CBTI completers had a mean PSQI reduction of 3.09 § 3.04, which was a very
large effect (t [21] = -4.77, p < .001, Cohen’s dz = 1.02). By comparison, a non-signiﬁcant change in PSQI scores was observed among
Black CBTI completers (-1.80 § 3.94; t [9] = -1.45, p = .182, Cohen’s
dz = .47).
Discussion
In a sample of 39 non-Hispanic Black and white pregnant women
with insomnia living in the United States, we observed racial disparities in treatment engagement and outcomes when treated with digital CBTI. White pregnant women had high treatment completion
rates in digital CBTI and reported large reductions in insomnia symptom severity and global sleep disturbance. By comparison, Black
pregnant women completed fewer sessions of digital CBTI and did
not report signiﬁcant treatment beneﬁts for either insomnia symptom severity or global sleep disturbance. Importantly, racial disparities in CBTI outcomes were robust and remained signiﬁcant even
when accounting for refractory cognitive arousal, which our team
has reliably linked to CBTI non-response.26,34,35 Overall, these ﬁndings indicate that patient uptake and treatment efﬁcacy of digital
CBTI may be reduced for Black pregnant women in the United States.
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Racial disparities in digital CBTI engagement
Pregnant women carry signiﬁcant burden for healthcare appointments—even women with healthy pregnancies—which include routine prenatal care, imaging, and tests among other wellness
appointments not directly related to pregnancy. Of course, healthcare
appointments are often more numerous for women with prenatal
complications, which require engagement in specialty clinics such as
maternal-fetal medicine. As pregnant women with untreated insomnia are at elevated risk for complications,10-12 it is critical to prioritize
easy access to insomnia care for these patients. Unfortunately, a paucity of trained providers with uneven geographic distribution
severely limits access to CBTI.36 To increase CBTI access, our group
and Felder’s team17,37 delivered CBTI digitally to maximize treatment
access for pregnant women who can easily feel over-taxed by healthcare appointments and tests.
Although digital CBTI engagement was high overall, the premature discontinuation rate for Black pregnant women was 4 times
higher than for white pregnant women (33.3% vs. 8.3%). Important to
emphasize here is that the observed racial disparities in treatment
engagement was unique to digital CBTI in the present study. By comparison, we explored racial differences in engagement in the sleep
education control intervention in this clinical trial, which revealed
equal engagement between Black and white pregnant women (see
supplementary materials). Thus, race-related differences in treatment engagement in this study were speciﬁc to digital CBTI. This
ﬁnding was different from a prior digital CBTI RCT in the non-perinatal patient population, which did not reveal differences in CBTI
engagement between Black and white insomnia patients.24 Importantly, these 2 trials were conducted using the same digital CBTI program and sampling from the same geographic location.24 In other
words, key aspects of the 2 RCTs were consistent across studies with
the main difference being the patient population, suggesting that
these racial disparities may be more signiﬁcant in a perinatal population. Even so, the racial disparity in digital CBTI engagement we
observed in pregnancy is highly consistent with the broader literature for mental health and behavioral interventions showing reduced
engagement for non-white patients.19-21
Along these lines, prenatal care utilization in the United States is
much lower for racial minorities as compared with white women.
Non-white pregnant women are less likely to initiate prenatal care or
access timely and affordable care, and they are also more likely to
delay prenatal care, attend fewer prenatal medical appointments,
and receive inadequate care.38-40 Moreover, inadequate healthcare
utilization is also reﬂected by reduced engagement in mental health
treatment (eg, perinatal depression and substance use disorders) for
non-white pregnant women.41-43 Given the low utilization of mental
health treatment among Black pregnant women, efforts to increase
minority treatment engagement in behavioral sleep interventions—
via digital format or otherwise—will play a critical role in closing the
racial gap in prenatal insomnia burden. Future research may focus on
comparing patient factors and social determinants between treatment completers vs. those who prematurely discontinue, which may
identify targets for enhancing patient uptake and engagement in digital health intervention.
Racial disparities in digital CBTI treatment response
After CBTI, white pregnant women reported very large reductions
in insomnia and global sleep disturbances, whereas Black pregnant
women did not report statistically signiﬁcant changes in these symptoms. Indeed, symptom reductions were twice as large for white
pregnant women relative to Black pregnant women. Consequently,
descriptive data suggested that white pregnant women may be
1.56 times more likely to remit after CBTI than Black pregnant
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women. These observed racial disparities in digital CBTI response are
highly consistent with the extant literature showing poorer mental
health treatment outcomes for racial minorities.19-21
Contrary to our hypotheses, the observed racial disparities in
treatment outcomes were not attributable to differences in session
completion. Rather, racial disparities in CBTI outcomes persisted
when accounting for dosage. Even Black pregnant women who
received an adequate dose of CBTI did not report signiﬁcant reductions in insomnia or global sleep disturbance. By contrast, white
pregnant women who completed CBTI reported very large reductions
in these symptoms. These data strongly suggest that poorer treatment outcomes for Black pregnant women are not entirely attributable to differences in the number of sessions completed.
Along these lines, racial disparities in CBTI response were observed
despite controlling for poverty status, obesity, and patient-reported
short sleep duration. Prior research shows that Black pregnant women,
relative to white pregnant women, report higher levels of poverty and
perinatal obesity, and report shorter sleep duration.9 Moreover, our
team has shown that elevated rates of prenatal insomnia among Black
women are attributable to these risk factors, such as the disproportionate number of Black women affected by poverty.9 But, despite these
other factors contributing to elevated insomnia rates for Black pregnant women, these factors did not account for the insufﬁcient
response to CBTI for Black pregnant women. More research is needed
to better understand barriers to insomnia treatment response for Black
women during pregnancy, which can guide enhancing the delivery of
insomnia therapy to this population. It is important to emphasize that
we captured patient-reported short sleep, but Black women have
shorter objective sleep duration than white women.44 Importantly,
objective short sleep is a potential barrier to CBTI response.45,46 Studies
are needed to evaluate the prevalence of the short sleep insomnia phenotype in pregnancy, and whether objective short sleep duration predicts CBTI response in this population.
Enhancing digital CBTI to improve treatment engagement and reduce
disparities
Social and structural determinants of insomnia. Pregnancy is a
stressful life event,47 and disproportionately so for Black Americans
who report higher levels of psychosocial stress, pregnancy-related
stress, and perceived racism relative to white Americans.6 By extension, pregnancy may exacerbate the pre-existing stress and limited
resources of underserved populations in the United States. And further compounding these issues is structural racism in prenatal care in
the United States that contributes to racial disparities in adverse
pregnancy and delivery outcomes.48 One potential avenue to
improve these racial disparities is to target social and structural
determinants of health and treatment engagement driving reduced
effectiveness/efﬁcacy of CBTI.
Social and structural determinants of health and treatment
engagement are complex, and many cannot be addressed by insomnia therapy. Rather, CBTI predominantly targets mechanisms on the
individual level (eg, sleep homeostasis), but not social and structural
factors such as the sleeping environment (eg, noise and light contamination, pollutants that impact breathing), familial arrangements (eg,
bed sharing with children, or sleeping on uncomfortable surfaces),
sleep-interfering work schedules (eg, shift work, unpredictable
schedules, multiple jobs), and stress and other psychological factors
(eg, ﬁnancial strain, increased vigilance due to neighborhood crime).
The COVID-19 pandemic has highlighted the need to address social
determinants of sleep disorders, which has inﬂuenced calls for structural interventions, such as increasing access to and engagement in
individual-level treatment, and including culturally relevant material
in sleep interventions (see Jackson and Johnson’s letter to the editor
for more potential roles and responsibilities for researchers and

clinicians to address social determinants of sleep health).49 Although
CBTI certainly cannot address all social determinants of health, any
modiﬁcations to CBTI that address social determinants of health, particularly those that may interfere with the ability to adhere to speciﬁc
CBTI components, may enhance its efﬁcacy in Black pregnant women.
To illustrate, a recent RCT supported good patient engagement and
treatment outcomes for a digital CBTI platform tailored to Black
women, which involved several changes for this population such as
modifying stimulus control for crowded living environments50; we
explore this RCT further in the next section.
Culturally tailored digital insomnia therapy. Along the lines of
including culturally relevant material in sleep interventions, it is
important to emphasize that Black Americans have positive appraisals of engaging in digital health treatment.51 Unfortunately, very few
digital health programs are developed using racially diverse patients,
which results in a severe lack of culturally tailored digital health
interventions.52 An emergent literature suggests that culturally tailored digital health tools may enhance treatment engagement and
outcomes in minority women.50,53-55
Indeed, a recent study examined the efﬁcacy of a digital CBTI program tailored for Black women, relative to one that was not tailored.
The tailored version included Black men and women in all visual content, modiﬁcations for stimulus control in a crowded living environment, and addressed neighborhood noise.50 Patients who received
the culturally tailored version were more likely to complete treatment than those without the tailored version (78% vs. 65% completion rate), and program completion was associated with greater
alleviation of insomnia symptoms.50 This study strongly supports culturally tailoring digital health interventions to enhance patient
engagement and treatment outcomes by offering a more inclusive
experience for patients. These ﬁndings are relevant to the present
study as the digital CBTI platform utilized here includes a cartoon
therapist avatar that is depicted as a white male. It is unclear whether
the avatar’s depicted race or sex may have inﬂuenced treatment
engagement among Black pregnant women in our study.
Going forward, the ﬁeld should adopt an equity lens in developing
and tailoring digital CBTI programs, which can include utilizing (1) a
diverse selection of virtual therapists for programs that utilize avatars,
(2) visual and presentation features that represent a diverse patient
population, (3) content (eg, case vignettes) that reﬂect the target
patient population, and (4) modiﬁes aspects of the intervention to
address social determinants of health (eg, environmental noise).50,56
Future studies may evaluate whether culturally tailored digital CBTI
programs may improve treatment engagement and outcomes relative
to the presently widely available standard programs that are more
geared to white patients. As treating prenatal insomnia reduces risk
for future maternal complications, including postpartum depression
and anxiety,37 then reducing racial disparities in prenatal insomnia via
insomnia therapy may consequently contribute to reducing disparities
in related outcomes such as postpartum depression and anxiety.
Study limitations and future directions
Study ﬁndings should be interpreted in the context of important
methodological limitations. The primary limitation for this study is
our inability to determine the extent to which group differences
observed here were related to the CBTI intervention vs. its digital
delivery. Future research is needed to determine whether these disparities are observed when CBTI is delivered to pregnant women by a
clinician (in-person or telemedicine). These data will be important
for guiding improvement for delivering insomnia therapy to nonwhite pregnant women. If racial disparities are observed for CBTI
irrespective of treatment delivery, then we must determine how to
make CBTI equally efﬁcacious across all races of pregnant women.
However, if racial disparities are only observed for digitally delivered
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CBTI, then these results would further support the need to create
diverse digital health intervention platforms.
Another important limitation concerns the assessment of treatment engagement. While session completion is an important indicator, several other engagement-related metrics can provide valuable
insight. Future investigations of racial disparities in treatment
engagement may evaluate adherence to prescribed sleep-wake
schedules, adherence to stimulus control, and completion of homework (eg, cognitive therapy and relaxation homework).
Third, as outlined above, Black Americans, and especially Black
pregnant women, are less likely to seek out and engage in treatment,
which has been linked to distrust in healthcare.57 Future studies
examining racial disparities in insomnia treatment engagement may
consider evaluating potential motivational factors associated with
treatment-seeking and engagement. Even so, it is important to highlight that we observed racial differences in digital CBTI response even
after accounting for treatment engagement in our multivariate
model, which indicates that future inquiry into improving CBTI
engagement and outcomes for Black pregnant women must go
beyond simply increasing engagement.56
Fourth, our study sample was small and only 2 racial groups had
sufﬁcient representation for analysis. Future research should explore
racial disparities in CBTI engagement and response in larger patient
samples, which may also allow for evaluation of treatment engagement and response in other racial groups that were insufﬁciently represented in the present study. Along the lines of generalizability, we
want to emphasize that it is unclear whether these observed racial
disparities are speciﬁc to the United States, or whether these results
generalize to other countries.
Conclusions
Insomnia symptoms affect approximately half of all women by the
end of pregnancy, but Black women are at substantially higher likelihood of experiencing prenatal insomnia than white women in the
United States. Although CBTI—when delivered by clinicians or via
digital format—is efﬁcacious in pregnancy, results from the present
study support racial disparities in treatment engagement and
patient-reported outcomes among pregnant women treated with
digital CBTI. Relative to white pregnant women, Black pregnant
women completed fewer sessions of digital insomnia therapy. Yet,
even among patients with high treatment engagement, Black pregnant women did not report therapeutic beneﬁts from digital CBTI. By
comparison, white pregnant women reported large sleep symptom
reductions. Future research is needed in 3 key areas: (1) determine
whether these study ﬁndings replicate in larger digital RCTs and in
trials using clinician-led CBTI treating pregnant women, (2) examine
whether treatment engagement and patient-reported outcomes differ for other racial groups in pregnancy, (3) enhance insomnia therapy and its digital delivery to improve treatment engagement and
outcomes for Black pregnant women with insomnia.
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